Price
Target price
€31.52
€31.52
2.180%
0.68
2.180%
€59.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Schott Pharma & Co. Kgaa
sharewise wants to provide you with the best news and tools for Schott Pharma & Co. Kgaa, so we directly link to the best financial data sources.
Financials
News
EQS-News: Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
EQS-News: Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
EQS-News: SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance
EQS-News: SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance
EQS-News: SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement
EQS-News: SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement
EQS-News: Transforming operational efficiency and sustainability: SCHOTT Pharma introduces nest design with more cavities for prefillable polymer syringes
EQS-News: Transforming operational efficiency and sustainability: SCHOTT Pharma introduces nest design with more cavities for prefillable polymer syringes
EQS-News: Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for on-body devices
EQS-News: Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for on-body devices
EQS-News: SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024
EQS-News: SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024
EQS-News: Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary
EQS-News: Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary
EQS-News: SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
EQS-News: SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations